The Synergistic Enhancement of Cloning Efficiency in Individualized Human Pluripotent Stem Cells by Peroxisome Proliferative-activated Receptor-γ (PPARγ) Activation and Rho-associated Kinase (ROCK) Inhibition.

Abstract

Although human pluripotent stem cells (hPSCs) provide valuable sources for regenerative medicine, their applicability is dependent on obtaining both suitable up-scaled and cost effective cultures. The Rho-associated kinase (ROCK) inhibitor Y-27632 permits hPSC survival upon dissociation; however, cloning efficiency is often still low. Here we have shown that pioglitazone, a selective peroxisome proliferative-activated receptor-γ agonist, along with Y-27632 synergistically diminished dissociation-induced apoptosis and increased cloning efficiency (2-3-fold versus Y-27632) without affecting pluripotency of hPSCs. Pioglitazone exerted its positive effect by inhibition of glycogen synthase kinase (GSK3) activity and enhancement of membranous β-catenin and E-cadherin proteins. These effects were reversed by GW-9662, an irreversible peroxisome proliferative-activated receptor-γ antagonist. This novel setting provided a step toward hPSC manipulation and its biomedical applications.

DOI: 10.1074/jbc.M114.624841
0500100020162017
Citations per Year

345 Citations

Semantic Scholar estimates that this publication has 345 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Kajabadi2015TheSE, title={The Synergistic Enhancement of Cloning Efficiency in Individualized Human Pluripotent Stem Cells by Peroxisome Proliferative-activated Receptor-γ (PPARγ) Activation and Rho-associated Kinase (ROCK) Inhibition.}, author={Nasim-Sadat Kajabadi and Ali Ghoochani and Maryam Peymani and Kamran Ghaedi and Abbas Kiani-Esfahani and Motahareh-Sadat Hashemi and Mohammad Hossein Nasr-Esfahani and Hossein Baharvand}, journal={The Journal of biological chemistry}, year={2015}, volume={290 43}, pages={26303-13} }